News
3d
MedPage Today on MSNHIV Drugs and Alzheimer's; Duchenne Drug Shows Benefit; PFAS and Cognitive ChangesNucleoside reverse transcriptase inhibitors -- antiretroviral drugs approved to treat HIV and hepatitis B -- were associated ...
The Manitoba government is pledging to give pharmacists more powers to prescribe medications, including birth control, ...
A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for repurposing in dementia prevention.
Alzheimer’s disease stands as the most widespread form of dementia globally, increasingly burdening families, healthcare systems, and societies as populations age. Although current treatments, ...
The use of nucleoside reverse transcriptase inhibitors, but not other HIV medicines, is linked to a reduced risk for ...
Share on Pinterest New research suggests that HIV drugs may have a protective effect against Alzheimer’s. Willie B. Thomas/Getty Images Researchers at UVA Health have found that a class of HIV ...
Hiding behind numerous disguises, HIV has been evading researchers for years, leaving the search for a vaccine as elusive as ...
The Trump administration’s dismantling of USAID has put more than 8,000 health workers in South Africa’s national HIV program ...
1d
Axios on MSNIllinois just made HIV drug PrEP easier to getAs the federal government cuts funding for HIV and AIDS research, Illinois is trying to make HIV prevention meds more ...
“Our results suggest that taking these drugs could prevent approximately 1 million new cases of Alzheimer’s disease every year.” NRTIs, or nucleoside reverse transcriptase inhibitors, are used to ...
A new study has found that a common class of medications could dramatically decrease the risk of developing the neurodegenerative disorder.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results